These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 18997279)

  • 21. The Roles of SPOP in DNA Damage Response and DNA Replication.
    Maekawa M; Higashiyama S
    Int J Mol Sci; 2020 Oct; 21(19):. PubMed ID: 33023230
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of a novel nuclear speckle-type protein, SPOP.
    Nagai Y; Kojima T; Muro Y; Hachiya T; Nishizawa Y; Wakabayashi T; Hagiwara M
    FEBS Lett; 1997 Nov; 418(1-2):23-6. PubMed ID: 9414087
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Speckle-type POZ protein suppresses lipid accumulation and prostate cancer growth by stabilizing fatty acid synthase.
    Gang X; Xuan L; Zhao X; Lv Y; Li F; Wang Y; Wang G
    Prostate; 2019 Jun; 79(8):864-871. PubMed ID: 30955223
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The BCL-6 POZ domain and other POZ domains interact with the co-repressors N-CoR and SMRT.
    Huynh KD; Bardwell VJ
    Oncogene; 1998 Nov; 17(19):2473-84. PubMed ID: 9824158
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Destruction of DDIT3/CHOP protein by wild-type SPOP but not prostate cancer-associated mutants.
    Zhang P; Gao K; Tang Y; Jin X; An J; Yu H; Wang H; Zhang Y; Wang D; Huang H; Yu L; Wang C
    Hum Mutat; 2014 Sep; 35(9):1142-51. PubMed ID: 24990631
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Structural basis of high-order oligomerization of the cullin-3 adaptor SPOP.
    van Geersdaele LK; Stead MA; Harrison CM; Carr SB; Close HJ; Rosbrook GO; Connell SD; Wright SC
    Acta Crystallogr D Biol Crystallogr; 2013 Sep; 69(Pt 9):1677-84. PubMed ID: 23999291
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Small-Molecule Targeting of E3 Ligase Adaptor SPOP in Kidney Cancer.
    Guo ZQ; Zheng T; Chen B; Luo C; Ouyang S; Gong S; Li J; Mao LL; Lian F; Yang Y; Huang Y; Li L; Lu J; Zhang B; Zhou L; Ding H; Gao Z; Zhou L; Li G; Zhou R; Chen K; Liu J; Wen Y; Gong L; Ke Y; Yang SD; Qiu XB; Zhang N; Ren J; Zhong D; Yang CG; Liu J; Jiang H
    Cancer Cell; 2016 Sep; 30(3):474-484. PubMed ID: 27622336
    [TBL] [Abstract][Full Text] [Related]  

  • 28. SPOP Regulates Endometrial Stromal Cell Decidualization in Mice.
    Liu N; Liu X; Yu Q; Chen X; Ding Y; He J; Gao R; Wang Y; Liu X
    Reprod Sci; 2016 Nov; 23(11):1565-1574. PubMed ID: 27170662
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nabais Sa-de Vries syndrome in a Chinese infant associated with a novel SPOP mutation: A clinical study and genetic report.
    Hu W; Fang H; Peng Y; Li L; Liu S; Liao H; Tang J; Yi J; Liu Q; Xu L; Wu L
    Mol Genet Genomic Med; 2022 Dec; 10(12):e2075. PubMed ID: 36259278
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Speckle-type POZ protein suppresses hepatocellular carcinoma cell migration and invasion via ubiquitin-dependent proteolysis of SUMO1/sentrin specific peptidase 7.
    Ji P; Liang S; Li P; Xie C; Li J; Zhang K; Zheng X; Feng M; Li Q; Jiao H; Chi X; Zhao W; Zhang S; Wang X
    Biochem Biophys Res Commun; 2018 Jul; 502(1):30-42. PubMed ID: 29777712
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dysregulation of INF2-mediated mitochondrial fission in SPOP-mutated prostate cancer.
    Jin X; Wang J; Gao K; Zhang P; Yao L; Tang Y; Tang L; Ma J; Xiao J; Zhang E; Zhu J; Zhang B; Zhao SM; Li Y; Ren S; Huang H; Yu L; Wang C
    PLoS Genet; 2017 Apr; 13(4):e1006748. PubMed ID: 28448495
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The emerging role of speckle-type POZ protein (SPOP) in cancer development.
    Mani RS
    Drug Discov Today; 2014 Sep; 19(9):1498-502. PubMed ID: 25058385
    [TBL] [Abstract][Full Text] [Related]  

  • 33. SPOP is essential for DNA-protein cross-link repair in prostate cancer cells: SPOP-dependent removal of topoisomerase 2A from the topoisomerase 2A-DNA cleavage complex.
    Watanabe R; Maekawa M; Hieda M; Taguchi T; Miura N; Kikugawa T; Saika T; Higashiyama S
    Mol Biol Cell; 2020 Mar; 31(6):478-490. PubMed ID: 31967940
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MacroH2A1.2 binds the nuclear protein Spop.
    Takahashi I; Kameoka Y; Hashimoto K
    Biochim Biophys Acta; 2002 Aug; 1591(1-3):63-8. PubMed ID: 12183056
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinico-pathological significance of the molecular alterations of the SPOP gene in prostate cancer.
    García-Flores M; Casanova-Salas I; Rubio-Briones J; Calatrava A; Domínguez-Escrig J; Rubio L; Ramírez-Backhaus M; Fernández-Serra A; García-Casado Z; López-Guerrero JA
    Eur J Cancer; 2014 Nov; 50(17):2994-3002. PubMed ID: 25204806
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The association of speckle-type POZ protein with lymph node metastasis and prognosis in cancer patients: A meta-analysis.
    Cheng F; Zeng C; Zeng L; Wu C; Chen Y
    Medicine (Baltimore); 2019 Oct; 98(40):e17439. PubMed ID: 31577764
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Speckle-type POZ protein mutations interrupt tumor suppressor function of speckle-type POZ protein in prostate cancer by affecting androgen receptor degradation.
    Lai J; Batra J
    Asian J Androl; 2014; 16(5):659-60. PubMed ID: 24969063
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The emerging role of SPOP protein in tumorigenesis and cancer therapy.
    Song Y; Xu Y; Pan C; Yan L; Wang ZW; Zhu X
    Mol Cancer; 2020 Jan; 19(1):2. PubMed ID: 31901237
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The CUL3-SPOP-DAXX axis is a novel regulator of VEGFR2 expression in vascular endothelial cells.
    Sakaue T; Sakakibara I; Uesugi T; Fujisaki A; Nakashiro KI; Hamakawa H; Kubota E; Joh T; Imai Y; Izutani H; Higashiyama S
    Sci Rep; 2017 Feb; 7():42845. PubMed ID: 28216678
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Speckle-type POZ protein is negatively associated with malignancies and inhibits cell proliferation and migration in liver cancer.
    Huang Y; Tan N; Jia D; Jing Y; Wang Q; Li Z; Zhang J; Liu L; Li J; Chen Z; He X
    Tumour Biol; 2015 Dec; 36(12):9753-61. PubMed ID: 26156804
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.